Development Obligations. 1. The College supports the development, production, and dissemination of copyrightable, trademarkable, patentable, and other intellectual properties by its employees.
Development Obligations i. The Lessee shall develop the Project as per the Development Milestones specified in Article
Development Obligations. 1. The College supports the development, production, and dissemination of intellectual property by its faculty members so long as those efforts support and do not detract from faculty member’s job duties.
Development Obligations i. The Licensee shall develop the Project as per the Development Milestones specified in Article 2.8 and approved designs and drawings, in accordance with the timelines set forth in the Agreement.
Development Obligations. You agree to do each of the following:
Development Obligations. 5.1 Development period and Milestone to be achieved by the Developer are as per details below:
Development Obligations. 9.1 The Licensee shall use its reasonable endeavours to develop, exploit and Market the Licensed Product in accordance with the Development Plan.
Development Obligations. The production, investment and employment targets set out in Sections 6.1, 6.2, 6.3, 6.4 and 6.5 of the Mining Convention are not binding upon Banro because the figures referred to in these sections are estimations and projections that may change depending on the local and international parameters relating to the stability of the country and the gold market.
Development Obligations. Each Party shall be responsible for carrying out its activities in accordance with the Development Plan. These activities shall include, without limitation (i) identifying and carrying out all major Development tasks to be conducted prior to submission of filings for Regulatory Approval of a Collaboration Product for a particular indication; (ii) identifying key Development objectives, expected associated resources, risk factors, timelines, go/no go decision points and relevant decision criteria; (iii) carrying out all aspects of (e.g., designing studies and protocols and conducting), and preparing the associated Regulatory Plan for, all clinical trials necessary to obtain Regulatory Approval for each indication pursued, as well as establishing new dosage forms, new formulations or other enhancements of approved Collaboration Products (but excluding Post-Approval Clinical Studies) including, but not limited to (1) establishing/contracting with clinical sites, investigators and contract research organizations ("CROs"), (2) enrolling clinical study patients, (3) organizing investigator meetings, scientific meetings, advisory panel workshops and regulatory meetings, and (4) analyzing, summarizing and presenting clinical study results; (iv) performing any other additional research and pre-clinical research in support of the clinical development of Collaboration Products; (v) forecasting clinical manufacturing production requirements; and (vi) Regulatory Authority reporting on study design, study outcome, other communications and regulatory filings (to the extent not covered by a Regulatory Plan).
Development Obligations. Ixsys shall use its commercially reasonable efforts to develop, as Ixsys determines is necessary or desirable, such Products as Ixsys determines are commercially feasible in the Territory.
